Establishing Durable Impact on Tumors through Phase 1 Evidence: Bench to Bedside & Back
- Establishing the path to clinical success to validate solid tumor treatments
- Uncovering clinical data to highlight robust clinical efficacy and durability
- Discussing package considerations to accelerate the path to commercialization